10-Year watch: how does DTX401 hold up in GSDIa patients?
NCT ID NCT06636383
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 37 times
Summary
This study follows about 140 people with Glycogen Storage Disease Type Ia who have already received the gene therapy DTX401. Researchers will track safety and how well the treatment works for at least 10 years. No new drug is given; participants simply attend regular check-ups to monitor side effects and changes in cornstarch use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLYCOGEN STORAGE DISEASE TYPE IA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Hospital Colorado
RECRUITINGDenver, Colorado, 80045, United States
-
Children's Hospital of Orange County
RECRUITINGOrange, California, 92868, United States
-
Children's Hospital of Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Duke University Medical Center
RECRUITINGDurham, North Carolina, 27710, United States
-
Fujita Health University Hospital
RECRUITINGToyoake, 470-1192, Japan
-
Groningen University
RECRUITINGGroningen, 9700 RB, Netherlands
-
Hospital Clínico Universitario de Santiago
RECRUITINGSantiago, 15706, Spain
-
Hospital de Clinicas de Porto Alegre (HCPA) - PPDS
RECRUITINGPorto Alegre, Rio Grande do Sul, 90035-903, Brazil
-
Istituto G Gaslini Ospedale Pediatrico IRCCS
RECRUITINGGenoa, 16147, Italy
-
McGill University Health Center
RECRUITINGMontreal, Quebec, H4A3J1, Canada
-
Osaka City General Hospital
RECRUITINGOsaka, 534-0021, Japan
-
Primary Children's Hospital
NOT_YET_RECRUITINGSalt Lake City, Utah, 84108, United States
-
Rigshospitalet
RECRUITINGCopenhagen, 2700, Denmark
-
The Cleveland Clinic Foundation
NOT_YET_RECRUITINGCleveland, Ohio, 44195, United States
-
University of Connecticut Health Center
RECRUITINGHartford, Connecticut, 06106, United States
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
-
University of Naples
RECRUITINGNaples, Campania, 80131, Italy
-
University of Texas Health Science Center at Houston
RECRUITINGHouston, Texas, 77030, United States
-
Universitätsklinikum Hamburg Eppendorf
RECRUITINGHamburg, 20246, Germany
Conditions
Explore the condition pages connected to this study.